Dermavance ready to launch

Berwyn, Pa. - DermAvance Pharmaceuticals, a privately held specialty dermatology pharmaceutical company, has appointed Keith A. Greathouse as president and chief executive officer. The company also announced the launch of its first products, including Vivelif, a topical therapy to address visible signs of aging.

Mr. Greathouse was formerly executive vice president for Sanofi-Aventis Dermatology (Dermik).